产品中心Cell Resources
联系我们CONTACT US
- 400-999-210024小时服务热线
产品概述
名称 | MDA-kb2 (人乳腺癌细胞) (STR鉴定正确) |
种属 | 人类 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:
培养条件:
气相:空气,100%, 温度:37℃
|
培养方案B(可选) |
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
|
推荐传代比例 | 1:2-1:5 |
推荐换液频率 | 2-3次/周 |
注意事项 | 1.该细胞推荐使用Leibovitz's L-15培养基进行培养,Leibovitz's L-15不可以通入二氧化碳,会产生细胞毒性;2.如您没有无二氧化碳的培养箱,可使用DMEM替代Leibovitz's L-15,使用DMEM培养基时即可正常通入5%二氧化碳;3.配套专用培养基默认Leibovitz's L-15配置,如需DMEM配方,请联系销售下单备注更改。 |
年龄(性别) | 女性;48岁 |
组织来源 | 乳腺 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 乳腺癌细胞 |
生物安全等级 | BSL-1 |
倍增时间 | 32-40 hours |
基因表达情况 | luciferase; The cell line expresses firefly luciferase under control of the MMTV promoter that contains response elements for both glucocorticoid receptors (GR) and androgen receptors (AR) |
保藏机构 | ATCC; CRL-2713 |
STR鉴定
-
STR位点信息
Amelogenin X CSF1PO 10,12 D2S1338 23,24 D3S1358 15 D5S818 11 D7S820 10 D8S1179 10,12 D13S317 12 D16S539 9 D18S51 15,20 D19S433 13,14 D21S11 29,31 FGA 18,23 PentaD 9,10 PentaE 11 TH01 6 TPOX 10 vWA 17,18 D6S1043 11,18 D12S391 18,21 D2S441 10 -
STR鉴定图
参考文献
-
Immunogenic cell death-related classification reveals prognosis and effectiveness of immunotherapy in breast cancer (2024-01-23)
作者:Lei Zhu:1.Department of General Surgery, Panjin Liao-Oil Field Gem Flower Hospital, Panjin, 124000, China. ; Yanmei Wu:1.Department of Rheumatology and Immunology, Panjin Liao-Oil Field Gem Flower Hospital, Panjin, 124000, China. ; Haichun Zhao:1.Department of General Surgery, Panjin Liao-Oil Field Gem Flower Hospital, Panjin, 124000, China. ; Zicheng Guo:1.Department of General Surgery, Panjin Liao-Oil Field Gem Flower Hospital, Panjin, 124000, China. ; Biao Bo:1.Department of General Surgery, Panjin Liao-Oil Field Gem Flower Hospital, Panjin, 124000, China. ; Li Zheng:1.Department of General Surgery, Panjin Liao-Oil Field Gem Flower Hospital, Panjin, 124000, China. zhengli_pj@163.com. ;
期刊:Immunogenic cell death-related classification reveals prognosis and effectiveness of immunotherapy in breast cancer
DOI:10.1038/s41598-024-52353-4
影响因子 :4.6
引用产品: MDA-kb2 细胞 , MDA-MB-231 细胞 , MCF7 [MCF-7] 细胞 , BT-549 细胞
-
Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity (2023-07-08)
作者:Yuting Zhang:1.Department of Breast Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, 510000, China. ; Yinghui Ye:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, 518000, China. ; Anping Xu:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, 518000, China. ; Yulou Luo:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, 830000, China. ; Yutian Sun:1.Department of Medical Oncology, School of Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, 610000, China. ; Wei Zhang:1.Department of Breast Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, 510000, China. zhangwei@jnu.edu.cn. ; Ling Ji:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, 518000, China. 1120303921@qq.com. ;
期刊:Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity
DOI:10.1007/s00432-023-05028-y
影响因子 :3.6
引用产品: MCF7 [MCF-7] 细胞 , MCF7 [MCF-7]细胞专用培养基 , BT-20 细胞 , BT-20细胞专用培养基 , MDA-MB-231 细胞 , MDA-MB-231细胞专用培养基 (L15) , MDA-kb2 细胞 , MDA-kb2细胞专用培养基 (L15) , HCC1937 细胞 , HCC1937细胞专用培养基
FAQs
Q:{{item.question}}
A:
产品资料
识别码示意图